Clinical Study of Nicardipine in 40 Patients with Hypertensive Emergency
OU Pan-wen
Abstract
OU Pan-wen
Abstract
Objective: To observe the clinic therapeutic effects and the side response of nicardipine in the treatment of patients with hypertensive emergency.Method: Forty patients with hypertensive emergencies were treated with intravenous nicardipine for infusion duration of twenty four hours. The nicardipine dose was 0.5~4μg/kg.min. Result: The blood pressure started to decrease when intravenous nicardipine was used for 10 minutes, and when 30 minutes the blood pressure was controlled satisfactorily. Conclusion: Nicardipine appears to be a safe and effective drug for intravenous use in the treatment of hypertensive emergencies. Intravenous nicardipine can rapidly and effectively lower blood pressure and its side effects are modest.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To observe the clinic therapeutic effects and the side response of nicardipine in the treatment of patients with hypertensive emergency.Method: Forty patients with hypertensive emergencies were treated with intravenous nicardipine for infusion duration of twenty four hours. The nicardipine dose was 0.5~4μg/kg.min. Result: The blood pressure started to decrease when intravenous nicardipine was used for 10 minutes, and when 30 minutes the blood pressure was controlled satisfactorily. Conclusion: Nicardipine appears to be a safe and effective drug for intravenous use in the treatment of hypertensive emergencies. Intravenous nicardipine can rapidly and effectively lower blood pressure and its side effects are modest.
Key concepts: Nicardipine, Medicine, Blood pressure, Anesthesia, Hypertensive emergency, Emergency department, Intravenous use, Drug